Intellia Therapeutics Announces Closing of Initial Public Offering

(NASDAQ:NTLA) today announced the closing of its initial public offering of 6,900,000 shares of its common stock at an initial public offering ...

Intellia Therapeutics Announces Closing of $690 Million Public ...

CAMBRIDGE, Mass. , July 02, 2021 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage genome editing company ...

Intellia Therapeutics Announces Pricing of Public Offering of ...

LLC is the sole underwriter for the offering. The offering is expected to close on or about December 2, 2022 , subject to customary closing ...

Intellia Therapeutics Announces Pricing of Initial Public Offering

(”Intellia Therapeutics” or “Intellia”) a leading gene editing company focused on the development of potentially curative therapeutics using ...

Intellia Therapeutics Announces Closing of $690 Million Public ...

Intellia Therapeutics, Inc., a leading clinical-stage genome editing company focused on developing curative therapeutics using CRISPR/Cas9 ...

Intellia Therapeutics Announces Pricing of Public Offering of ...

(NASDAQ:NTLA), a leading genome editing company focused on developing curative therapeutics using CRISPR/Cas9 technology both in vivo and ex ...

Intellia Therapeutics Completes $600 Million Public Offering ...

(Nasdaq: NTLA) on its $690 million underwritten public offering on the heels of releasing the first-ever clinical data supporting safety and ...

Intellia Therapeutics announces pricing of initial public offering

* Says initial public offering of 6.00 million common shares priced at $18.00per share Source text for Eikon: Further company coverage: Get a ...

Intellia Therapeutics Announces Closing of $201 Million Public ...

CAMBRIDGE, Mass., Dec. 04, 2020 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading genome editing company focused on developing ...

Intellia Therapeutics Announces Pricing of Public Offering of ...

Intellia Therapeutics Announces Pricing of Public Offering of Common Stock ... CAMBRIDGE, Mass. , Nov. 01, 2017 (GLOBE NEWSWIRE) -- Intellia ...

FORM S-1 - SEC.gov

... Intellia Therapeutics, LLC received restricted common stock in Intellia Therapeutics ... stock into common stock upon the closing of an initial public offering.

Press Releases - Intellia Therapeutics - investor relations

Expects to report initial data from Phase 1 study of NTLA-2001, a ... Intellia Therapeutics Announces Closing of $201 Million Public Offering of ...

Oriental Rise Holding Limited Announces Closing of Initial Public ...

The company's shares began trading on the Nasdaq Capital Market on October 17, 2024. The gross proceeds from the offering totaled $7 million, ...

News | Intellectual Property & Industry Research Alliances

March 18, 2024. Intellia Therapeutics Announces First ... May 11, 2016. Intellia Therapeutics Announces Closing of Initial Public Offering(link is external).

NTLA SEC Filings - Intellia Therapeutics, Inc.- Annual Report, Proxy ...

Press Releases (Most Recent) ; 2024-06-14, Intellia Therapeutics Names Brian Goff to its Board of Directors) ; 2024-05-09, Intellia Therapeutics Announces First ...

Intellia Therapeutics Announces Proposed Public Offering of

01, 2017 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (Nasdaq:NTLA), a leading genome editing company focused on the development of ...

ProPhase Labs Announces Closing of Public Offering of Common ...

Shares were sold at $0.72 per share, generating gross proceeds of approximately $3.45 million. The company plans to use proceeds for working ...

Intellia Therapeutics - Wikipedia

Intellia Therapeutics, Inc. is an American clinical-stage biotechnology company focused on developing novel, potentially curative therapeutics leveraging ...

Intellia Raises $300 Million in Public Offering of Common Stock

Genome editing biotech Intellia Therapeutics said it priced an underwritten public offering of 6.6 million shares of its common stock at a ...

Gene-editing Company Intellia Therapeutics Files for a $120 Million ...

On Monday April 11th, Intellia Therapeutics filed for an IPO to raise up to $120 million. Founded in 2014, Intellia Therapeutics (to be Nasdaq: ...